Background: Orthostatic hypotension (OH) is a reduction in systolic blood pressure (BP) of ≥20 mmHg and/or diastolic BP of ≥10 mmHg within three minutes of standing. It is thought OH may increase the risk of cognitive impairment (CI) due to cerebral hypoperfusion (CH). It is unclear whether OH and CI coexist due to underlying neurodegeneration, or whether OH increases the risk of CI through CH. This study aims to assess whether baseline OH is associated with cognitive decline.
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Methods: Data from waves 1 and 3 (4 year interval) of The Irish Longitudinal Study on Ageing (TILDA), a prospective cohort study comprising of community dwelling people ≥50, were used. Participants who attended for health assessment (HA) at both waves were included. Individuals with diagnosed dementia, stroke or Parkinson's at baseline, or who had received diagnosis of stroke or Parkinson's at follow-up, were excluded. Beat-tobeat BP during an active-stand (AS) lasting 110 seconds was measured using a Finometer. OH110 was defined as OH sustained up to 110 seconds post stand. A composite error score for MOCA and MMSE was used to assess cognition (log(60-(MMSE + MOCA) + 3)). Results: 3,115 participants who had HA at both waves and adequate AS data at wave 1 were included. 127 (4.08%) of these had OH110. Using Mixed effects analysis, OH110 was associated with an increase in the cognitive error score at follow-up (0.12, p-value 0.001), with adjustment for con-founders. Based on adjusted mean margins, cognition improved between wave 1 and 3 in participants without OH110 (2.02-1.94, p < 0.001). Participants with OH110 had higher error score at follow-up (2.05-2.10, p < 0.001) Conclusion: TILDA offers a unique opportunity to assess implications of OH on cognition, using beat-to-beat BP measurement. In this study, OH110 was associated with cognitive decline in community dwelling adults over the age of 50 at 4 year follow-up.
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